Top > News Releases

Y's Therapeutics Announced as follows the change of the board members on August 1, 2007



Detail of Change

Name	New Position	Former Position
Masanori Murayama	Representative Director and President and CEO	Representative Director and Chairman
Nobuo Kato	Representative Director and Senior Vice-President and COO	Representative Director and President

About Y's Therapeutics
Y's Therapeutics (http://www.ysthera.com) is a privately held biopharmaceutical company engaged in the R&D of novel therapeutics for the treatment of inflammation-mediated diseases, cancer, and other unmet medical needs. Y's focuses on the development of preclinical and early-stage clinical projects pursued through research collaborations and in-licensing opportunities from academic institutions and biotech companies. Y's is seeking collaborative relationships, including out-licensing of product rights and creation of joint ventures, for late-stage development, manufacturing and commercialization of its portfolio products. The company currently has several projects in its clinical and preclinical pipeline. Y's has operations in two locations, Y's Therapeutics Co., Ltd., of Tokyo, Japan, and Y's Therapeutics, Inc., of Burlingame, CA.

◈CONTACT◈
Kyoko Harigae
Administrations Department
Y's Therapeutics Co., Ltd.
+011-81-3-5784-2762
E-Mail：admin@ysthera.com

Top  |  Site Map  |  Access Map  |  Privacy Policy  |  Terms of Use